BSE filing, NSE: NIRAJ. Summary written from the filing by ALFA Finder's alert engine.
Niraj Cement Structurals Ltd: key numbers
- Share price
- ₹24.50
- Market cap
- ₹146.2 Cr
- Revenue (annual)
- ₹542.0 Cr
- Net profit (annual)
- ₹21.14 Cr
- P/E (TTM)
- 6.2×Sector 31.7×
- Promoter holding
- 24.93%+0.04% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Niraj Cement Structurals Ltd
All →Niraj Cement Structurals Annual General Meeting
Niraj Cement Structurals Limited conducted its 28th Annual General Meeting on September 28, 2026. All agenda resolutions presented at the meeting were approved by shareholders.
Niraj Cement Structurals Annual General Meeting
Niraj Cement Structurals Limited has issued the notice for its 28th Annual General Meeting scheduled for September 28, 2026, along with the Annual Report for FY 2025-26.
Niraj Cement Structurals Merger & Restructuring
Niraj Cement Structurals Limited has incorporated a new subsidiary, Niraj Group Foundation. The Section 8 company will handle the group's social welfare and CSR activities.
Niraj Cement Structurals Open Offer: ₹0.06 Cr
Gulshankumar Vijaykumar Chopra completed an open offer for Niraj Cement Structurals Ltd. The acquirer acquired 21,350 shares at Rs. 29 each, totaling Rs. 0.06 Crore.
- Value
- ₹0.06 Cr
Niraj Cement Structurals Q1 FY27 Results: Net Profit ₹3.6 Cr, Up 260.0% YoY
Niraj Cement Structurals Ltd reported revenue from operations of ₹104.5 Cr (+10.6% YoY) and net profit of ₹3.6 Cr (+260.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹3.6 Cr · +260.0% YoY
Niraj Cement Structurals Board Meeting Date
Niraj Cement Structurals Limited has scheduled a board meeting on August 13, 2026, to consider the company's unaudited standalone and consolidated financial results.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.